$user = $this->Session->read('Auth.User');
//find the group of logged user
$groupId = $user['Group']['id'];
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '19974',
'hit' => '498'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://old.newbusinessage.com/app/webroot/img/news/20240114072912_collage (10).jpg'
$user = null
include - APP/View/Articles/view.ctp, line 115
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Notice (8): Trying to access array offset on value of type null [APP/View/Articles/view.ctp, line 115]
$user = $this->Session->read('Auth.User');
//find the group of logged user
$groupId = $user['Group']['id'];
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '19974',
'hit' => '498'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://old.newbusinessage.com/app/webroot/img/news/20240114072912_collage (10).jpg'
$user = null
include - APP/View/Articles/view.ctp, line 115
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Notice (8): Trying to access array offset on value of type null [APP/View/Articles/view.ctp, line 116]
//find the group of logged user
$groupId = $user['Group']['id'];
$user_id=$user["id"];
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '19974',
'hit' => '498'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://old.newbusinessage.com/app/webroot/img/news/20240114072912_collage (10).jpg'
$user = null
$groupId = null
include - APP/View/Articles/view.ctp, line 116
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
$viewFile = '/var/www/html/newbusinessage.com/app/View/Articles/view.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '19974',
'hit' => '498'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$image = 'https://old.newbusinessage.com/app/webroot/img/news/20240114072912_collage (10).jpg'
$user = null
$groupId = null
$user_id = null
$date = '2024-01-14 07:26:40'
$dateFromDatabase = (int) 1705196500
$newDate = 'Jan 14, 2024'
$articleView = array(
'article_id' => '19974',
'hit' => '498'
)
$word_count = (int) 419
$time_to_read = (float) 2.1
$time_to_read_min = (float) 2
$time_to_read_second = (float) 6
include - APP/View/Articles/view.ctp, line 241
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public.
General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.
This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.
Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.
Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.
Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.
NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.
According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)
FormHelper::create() - CORE/Cake/View/Helper/FormHelper.php, line 383
include - APP/View/Articles/view.ctp, line 273
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '19974',
'hit' => '498'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
include - APP/View/Elements/side_bar.ctp, line 60
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Warning (2): simplexml_load_file() [<a href='http://php.net/function.simplexml-load-file'>function.simplexml-load-file</a>]: I/O warning : failed to load external entity "" [APP/View/Elements/side_bar.ctp, line 60]
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '19974',
'hit' => '498'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
simplexml_load_file - [internal], line ??
include - APP/View/Elements/side_bar.ctp, line 60
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
file not found!
Notice (8): Undefined variable: file [APP/View/Elements/side_bar.ctp, line 133]
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '19974',
'hit' => '498'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$xml = false
include - APP/View/Elements/side_bar.ctp, line 133
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
Warning (2): simplexml_load_file() [<a href='http://php.net/function.simplexml-load-file'>function.simplexml-load-file</a>]: I/O warning : failed to load external entity "" [APP/View/Elements/side_bar.ctp, line 133]
$viewFile = '/var/www/html/newbusinessage.com/app/View/Elements/side_bar.ctp'
$dataForView = array(
'article' => array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
[maximum depth reached]
)
),
'Slider' => array()
),
'current_user' => null,
'logged_in' => false
)
$article = array(
'Article' => array(
'id' => '19974',
'article_category_id' => '1',
'title' => 'Nepal Drug Ltd to Produce 20 Additional Medicines',
'sub_title' => '',
'summary' => 'Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.',
'content' => '<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">January 14: Nepal Drug Limited (NDL) is set to boost its pharmaceutical production by introducing 20 additional medicines, covering 98 different drug categories, for free distribution to the public. </span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">General Manager Kailash Kumar Paneru revealed that the NDL plans to independently manufacture these medicines and supply them to the government.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">This initiative comes in response to the Prime Minister's directive to mobilize resources and enhance trade activities. The Ministry for Industry and Commerce has also entered into an agreement to support the commercial sustainability and capacity building of NDL.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Historically, the company has produced 146 types of medicines, but over time, the variety declined to nine, and currently, it only manufactures CETAMOL. In an effort to revitalize the company, there is an emphasis on investment and diversification of production.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Despite facing challenges in market competition and technological limitations, General Manager Paneru is optimistic. He believes that following the Prime Minister's guidance and implementing a robust work plan will help the company compete effectively. Paneru stressed the need for capacity building to expand production capabilities.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">Assuring the quality of medicines, Paneru mentioned that the drugs would be sold and distributed in collaboration with all local levels across the country. The company has witnessed an increase in production and sales, achieving a notable milestone of selling drugs worth Rs 10.5 million in the previous month alone.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">NDL Chairperson Yagya Prasad Neupane shared the company's objective to produce 98 types of drugs for government distribution. Additionally, the company plans to leverage its land for income generation, intending to establish a commercial medical hub and expand production capacity to enhance competitiveness in the pharmaceutical industry.</span></span></p>
<p><span style="font-size:20px"><span style="font-family:Calibri,"sans-serif"">According to the Trade and Export Promotion Centre, the import of medicine-related products amounted to Rs 16.80 billion in the first five months of the current fiscal year (2080/81). (RSS)</span></span></p>
<p> </p>
',
'published' => true,
'created' => '2024-01-14',
'modified' => '2024-01-14',
'keywords' => '',
'description' => '',
'sortorder' => '19701',
'image' => '20240114072912_collage (10).jpg',
'article_date' => '2024-01-14 07:26:40',
'homepage' => false,
'breaking_news' => false,
'main_news' => true,
'in_scroller' => false,
'user_id' => '42'
),
'ArticleCategory' => array(
'id' => '1',
'name' => 'NEWS',
'parentOf' => '0',
'published' => true,
'registered' => '2015-07-20 00:00:00',
'sortorder' => '158',
'del_flag' => '0',
'homepage' => true,
'display_in_menu' => true,
'user_id' => '1',
'created' => '0000-00-00 00:00:00',
'modified' => '2018-11-22 11:58:49'
),
'User' => array(
'password' => '*****',
'id' => '42',
'user_detail_id' => '1',
'group_id' => '1',
'username' => 'karkiushak@gmail.com',
'name' => null,
'email' => 'karkiushak@gmail.com',
'address' => null,
'gender' => null,
'access' => '1',
'phone' => null,
'access_type' => null,
'activated' => true,
'sortorder' => null,
'published' => null,
'created' => '2022-12-08 15:31:54',
'last_login' => '2024-08-13 15:00:05',
'ip' => '172.68.250.137'
),
'ArticleComment' => array(),
'ArticleFeature' => array(),
'ArticleHasAuthor' => array(),
'ArticleHasTag' => array(),
'ArticleView' => array(
(int) 0 => array(
'article_id' => '19974',
'hit' => '498'
)
),
'Slider' => array()
)
$current_user = null
$logged_in = false
$xml = false
simplexml_load_file - [internal], line ??
include - APP/View/Elements/side_bar.ctp, line 133
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::_renderElement() - CORE/Cake/View/View.php, line 1224
View::element() - CORE/Cake/View/View.php, line 418
include - APP/View/Articles/view.ctp, line 391
View::_evaluate() - CORE/Cake/View/View.php, line 971
View::_render() - CORE/Cake/View/View.php, line 933
View::render() - CORE/Cake/View/View.php, line 473
Controller::render() - CORE/Cake/Controller/Controller.php, line 968
Dispatcher::_invoke() - CORE/Cake/Routing/Dispatcher.php, line 200
Dispatcher::dispatch() - CORE/Cake/Routing/Dispatcher.php, line 167
[main] - APP/webroot/index.php, line 117
